Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NATRUL-3: HMPL-004 in mild to moderate ulcerative colitis
NCT01805791Phase 3Terminated
- Sponsor
- Hutchison MediPharma (HMP)
- Start
- Mar 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of andrographolide in ulcerative colitis (UC), sponsored by Hutchison MediPharma (HMP). Started Mar 2013; status: terminated.
02
Drugs
andrographolide
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01805791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01805791.